Publications by authors named "Tarik Azzi"

Claim this Profile
A
A metabolic dependency of EBV can be targeted to hinder B cell transformation.
Bojana Müller-Durovic, Jessica Jäger, Christine Engelmann, Patrick Schuhmachers, Sabine Altermatt, Tarik Azzi

Science· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes.
Semjon Sidorov, Lara Fux, Katja Steiner, Samyo Bounlom, Sabrina Traxel, Tarik Azzi

Cancer Immunol Immunother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced frequency of cytotoxic CD56 CD16 NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.
Elena Pánisová, Anna Lünemann, Simone Bürgler, Monika Kotur, Julien Lazarovici, Tarik Azzi

Cancer Immunol Immunother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56NKG2AKIR NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
Janice K P Lam, Tarik Azzi, K F Hui, Aikha M G Wong, Donal McHugh

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Tarik Azzi

PLoS Pathog· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Tarik Azzi

PLoS Pathog· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.
Bithi Chatterjee, Yun Deng, Angelika Holler, Nicolas Nunez, Tarik Azzi

PLoS Pathog· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.
Zakia Djaoud, Lisbeth A Guethlein, Amir Horowitz, Tarik Azzi, Neda Nemat-Gorgani

J Exp Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Kristina Kakalacheva, Stephan Regenass, Silke Wiesmayr, Tarik Azzi, Christoph Berger

Viruses· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role for early-differentiated natural killer cells in infectious mononucleosis.
Tarik Azzi, Anna Lünemann, Anita Murer, Seigo Ueda, Vivien Béziat

Blood· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection.
Seigo Ueda, Satoshi Uchiyama, Tarik Azzi, Claudine Gysin, Christoph Berger

J Infect Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate immune responses against Epstein Barr virus infection.
Obinna Chijioke, Tarik Azzi, David Nadal, Christian Münz

J Leukoc Biol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A distinct subpopulation of human NK cells restricts B cell transformation by EBV.
Anna Lünemann, Liliana D Vanoaica, Tarik Azzi, David Nadal, Christian Münz

J Immunol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis